Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001651175-25-000007·Evoke Pharma Inc
Schedule 13D ownership disclosure
EVOKE PHARMA INC
Common Stock, par value $0.0001 per share · CUSIP: 30049G302
Event date: 2025-11-04
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Klein Roger M.Reported CIK 0001651175
Shares: 163,000.00 · Class: 10.5%
- Krieger Charitable Trust
Shares: 129,000.00 · Class: 8.3%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001651175-25-000007
- Form type
- SCHEDULE 13D
- Filer
- Evoke Pharma Inc
- CIK
- CIK 1403708
- Filed
- Nov 12, 2025
- Reporting period
- Nov 04, 2025
- Description
- Schedule 13D beneficial ownership